InSysBio to announce the upgrade of its SbmlViewer application to version 0.2.7

NEWS
Press-Release
January 26, 2021

Januay 26, 2021

[Moscow – 26.01.2021] InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, launces the new version of its SbmlViewer open project. Generally, SbmlViewer represents a tool for fast and easy reading of biological models written in SBML format. Its main feature is to provide an opportunity to look through model components and equations even if a user has no modeling software installed.

Actually, the process becomes as simple as viewing a web page in your browser. Moreover, its usage is secure for a code since SbmlViewer never uploads your files to the server and all transformations are performed locally in your browser. SbmlViewer is extremely helpful in the following cases: a user needs to share a model in human readable and compact format; a user cannot install his favorite tool to read and check some SBML file; some software cannot read some specific SBML elements but the file includes them; a user has some errors when importing SBML and checking the model code.

Evgeny Metelkin, Head of Product Development, comments on the update, “The major new feature of this version is the ability to convert SBML to Heta format. Previously SbmlViewer maintained the transformation only to tabular and mathematical formats”.

Version 0.2.7 performs the following functions:

  • reading SBML Level 2 Version 1-5;
  • reading SBML Level 3 Version 1-2;
  • transformation to Heta code using sbml2heta or sbml3heta;
  • creating tabular view of model with: sbml2table or sbml3table transformation;
  • summary generation for chosen element: sbml2element transformation;
  • generation of ODE system based on your model: sbml2math or sbml3math transformation;
  • supports specific SBML format generated by simbiology by transforming MathML and using name instead of id;
  • supports printing the whole document to page or pdf.

SbmlViewer is an open project located on GitHub

For more information, please visit sv.insysbio.com

About InSysBio

InSysBio is a Quantitative Systems Pharmacology (QSP) company located in Moscow, Russia (INSYSBIO LLC) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s innovative QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 120 completed projects in collaboration with leaders of pharmaceutical industry. For more information about InSysBio, its solutions and services, visit www.insysbio.com.

July 2022
MoTuWeThFrSaSu
    
1
2
3
4
5
6
7
8
9
10
11
1. 11 Jul 2022 16:05 InSysBio team to publish the new article in Journal of Pharmacokinetics and Pharmacodynamics The new article "Application of different approaches to generate virtual patient populations for the quantitative systems pharmacology model of erythropoiesis" by Galina Kolesova, Alexander Stepanov, Galina Lebedeva and Oleg Demin has been recently published.
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
1. 27 Jul 2022 12:37 InSysBio to present posters at AAIC 2022 InSysBio announces its participation in AAIC 2022 (Online). Alzheimer’s Association International Conference is held July 31 – August 4, 2022 in San Diego, USA and Online. InSysBio Neurodegeneration Diseases team presents three posters within its frames
28
29
30
31
Upcoming Events
Tags
Latest News
11.07
InSysBio team to publish the new article in Journal of Pharmacokinetics and Pharmacodynamics
24.05
InSysBio to establish a new legal entity in Cyprus
25.04
InSysBio's ASCPT 2022 Micro-Theater Session on YouTube
20.01
InSysBio to release Immune Response Template v. 3.6.0
23.12
InSysBio to update CYTOCON DB and CYTOCON DB Open